Effectiveness of Clinical Pathway in Breast Cancer Patients: A Meta-Analysis
DOI:
https://doi.org/10.12974/2309-6160.2014.02.01.3Keywords:
Breast neoplasms, Critical Pathways, Meta-analysis.Abstract
Purpose: To evaluate the use of clinical pathways (CPs) for breast cancer when compared with usual medical care. Methods: The Cochrane Library, PubMed, EMBASE, Web of science and four Chinese databases were searched from inception to November 2012 to identify randomized controlled trials (RCTs) that reported the effect of CPs for breast cancer. Two reviewers independently selected studies, extracted data and assessed included studies. The assessment of methodological quality of the included studies was based on the Jadad score. Meta-analyses were performed using RevMan software (version 5.2). Results: Six randomized controlled trials (597 patients) were included. There were 297 patients in the CPs group and 300 patients in the usual medical care group. The results showed that compared with usual medical care, CPs could significantly shorten the length of hospital stay (MD = -3.83d, 95% confidence interval [CI] [-5.20, -2.46]), decreased hospitalization costs (SMD = -3.44, 95%CI, [-4.79, -2.09]) and preoperative hospitalization (MD = -0.56d, 95%CI, [-0.77, -0.34]). There was no statistically difference in patients’ satisfaction (OR =2.39, 95%CI, [1.00, 5.70]) and postoperative complications (OR = 0.34, 95%CI, [0.11, 1.08]). Conclusions: The current evidence showed that CPs could effectively improve the quality of the care provided to the breast cancer patient. It may be able to shorten the length of hospital stay, decreased hospitalization costs and preoperative hospitalization.
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E,Forman D. Global cancer statistics. Cancer J Clin 2011; 61(2): 69-90. http://onlinelibrary.wiley.com/doi/10.3322/caac.20107/full?dm msmid=71827&dmmspid=19396336&dmmsuid=1908926.
Porter P. “Westernizing” women's risks? Breast cancer in lower-income countries. N Engl J Med 2008; 358(3): 213-6. http://www.nejm.org/doi/full/10.1056/nejmp0708307
Zhang Y, Pan B,Sun Q. The reviewe of prevention and treatment of breast cancer. Chinese J Clin (Electronic Edition) 2012; 8(16): 4806-10. http://d.wanfangdata.com.cn/periodical_zhlcyszz201216058. aspx
Campbell H, Hotchkiss R, Bradshaw N,Porteous M. Integrated care pathways. Br Med J 1998; 316(7125): 133-7. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2665398/
Rotter T, Kinsman L, James E, Machotta A, Gothe H, Willis J, et al. Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev 2010; 3(3). http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD0066 32.pub2/abstract
Barbieri A, Vanhaecht K, Van Herck P, Sermeus W, Faggiano F, Marchisio S, et al. Effects of clinical pathways in the joint replacement: a meta-analysis. BMC Med 2009; 7(1): 32. http://www.biomedcentral.com/1741-7015/7/32/
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17(1): 1-12. http://www.sciencedirect.com/science/article/pii/0197245695 001344
SCHULTZ K. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273(5): 408-12. http://jama.jamanetwork.com/article.aspx?articleid=386770
Wang S. The application of clinical pathway in patients with breast cancer surgery. Anhui Medical and Pharmaceutical Journal 2007; 11(3): 245. http://www.cnki.com.cn/Article/CJFDTotal- AHYY200703033.htm
Rong H. Clinical pathway and care pathway for 80 breast cancer cases. Journal of Nantong University (Medical Sciences) 2007; 27(3): 223-4. http://www.cqvip.com/qk/94483a/200703/24463044.html
Zhang Y. The application of clinical pathway in neoadjuvant chemotherapy for breast cancer patients. Today Nurse 2010; 8: 92-3. http://d.wanfangdata.com.cn/periodical_ddhszkb201008056. aspx
Jiang D. Clinical value of the execution of clinical pathway in the treatment of breast cancer. Jilin University; 2009. http://cdmd.cnki.com.cn/Article/CDMD-10183- 2009092984.htm
Mo X. Integrated Chinese Western clinical pathway in breast cancer perioperative period. Hebei Medicine 2011; 17(3): 365-7. http://www.cnki.com.cn/Article/CJFDTotal- HCYX201103033.htm
Liu P, Li X, Zhong S, Chen Q, Lin Y, Ren L, et al. Analysis of clinical pathway implementation for breast cancer in perioperative period combined with traditional Chinese and Western medicine. Lingnan Modern Clinics in Surgery 2007; 7(5): 350-3. http://d.wanfangdata.com.cn/periodical_lnxdlcwk200705012. aspx
CHEAH J. Development and implementation of a clinical pathway programme in an acute care general hospital in Singapore. Int J Qual Health Care 2000; 12(5): 403-12. http://www.ncbi.nlm.nih.gov/pubmed/11079220
Bosch C, Vogel S, Schrappe M, Grischke EM, Seyfarth- Metzger I,Breitscheidel L. Controlling the cost of care of breast cancer patients in germany using clinical pathways. Value Health 2010; 13(3): A49. http://www.valueinhealthjournal.com/article/S1098- 3015(10)72223-3
Hogeveen S, Han D, George RL, Sweet-Goldstein M, Dinniwell RE, Muradali D, et al. Improvement in the quality of care for patients with locally advanced breast cancer through implementation of an integrated electronic care pathway. J Clin Oncol 2011; 29(27): suppl. 27: abstr 207. http://meetinglibrary.asco.org/content/86061-111
Richter-Ehrenstein C, Schneider A, Kramer M, Heymann S, Schmidt D, Eveslage K, et al. A clinical pathway in breast cancer surgery: Pathway monitoring and impact. Geburtshilfe Frauenheilkd 2009; 69(7): 617-22. http://cat.inist.fr/?aModele=afficheN&cpsidt=21672222
Santoso U, Iau PTC, Lim J, Koh CSL,Pang YT. The mastectomy clinical pathway: What has it achieved? Ann Acad Med Singapore 2002; 31(4): 440-5. http://europepmc.org/abstract/MED/12161878
Every NR, Hochman J, Becker R, Kopecky S,Cannon CP. Critical pathways: a review. Circulation 2000; 101(4): 461-5. http://circ.ahajournals.org/content/101/4/461.short
Nichol G, Walls R, Goldman L, Pearson S, Hartley LH, Antman E, et al. A critical pathway for management of patients with acute chest pain who are at low risk for myocardial ischemia: recommendations and potential impact. Ann Intern Med 1997; 127(11): 996-1005. http://annals.org/article.aspx?articleid=710990
Ogilvie-Harris D, Botsford D,Hawker RW. Elderly patients with hip fractures: improved outcome with the use of care maps with high-quality medical and nursing protocols. J Orthop Trauma 1993; 7(5): 428-37. http://journals.lww.com/jorthotrauma/Abstract/1993/10000/El derly_Patients_with_Hip_Fractures__Improved.5.aspx
Pearson SD, Goulart-Fisher D,Lee TH. Critical pathways as a strategy for improving care: problems and potential. Ann Intern Med 1995; 123(12): 941-8. http://annals.org/article.aspx?articleid=709286
Hwang TG, Wilkins EG, Lowery JC,Gentile J. Implementation and evaluation of a clinical pathway for TRAM breast reconstruction. Plast Reconstr Surg 2000; 105(2): 541-8. http://journals.lww.com/plasreconsurg/Abstract/2000/02000/I mplementation_and_Evaluation_of_a_Clinical.10.aspx
